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1, Introduction 
The hepatic cell contains a cytosolic acetyl-CoA 
acetyltransferase, a mitochondrial acetyl-CoA acyl- 
transferase (EC 2.3.1.16) and acetyl-CoA acetyltrans- 
ferase as well as a peroxisomal acetyl-CoA acyltrans- 
ferase [l-3]. The mitochondrial acetyl-CoA acetyl- 
transferase (mAAT) (EC 2.3.1.9), which catalyzes the 
first step in the biosynthesis of ketone bodies, has 
been shown to exist in two forms, transferases A and 
B [2], Its transferase activity increases in metabolic 
situations with an elevated ketonaemia 141, and evi- 
dence has been reported that the enzyme is involved 
in the regulation of ketogenesis [2,5-71. The aim of 
the study was to quantitate the amount of mAAT 
present in crude liver homogenates from rats under 
various metabolic conditions. In view of the numerous 
transferase activities pregent in a crude liver homoge- 
nate we used an immunochemical assay with anti- 
bodies raised against the purified enzyme. Our results 
demonstrate that the amount of mAAT remains 
unchanged under conditions in which the rate of keto- 
genesis differs considerably. This indicates that, in 
vivo, the activity rather than the amount of enzyme 
protein is modulated. 
2. Materials and methods 
Acute diabetes was induced in rats by alloxan injec- 
tions [ 51. Liver homogenates were prepared by con- 
ventional homogenization and centrifugations and the 
mitochondria were solubilized in a medium containing 
Abbreviation: mAAT, mitochondrial acetylCoA acetyltrans- 
ferase 
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0.05 M sodium phosphate (pH 6.6), 1 mM EDTA, 
0.5 mM dithioerythritol, 20% (w/v) glycerine and 
0.5% (w/v) Triton X-100. Then the homogenates were 
centrifuged for 60 min at 105 000 X g. DNA was 
determined as in [8]. Acetyl-CoA acetyltransferase 
activity was assayed in the presence of 80 mM potas- 
sium [2]. Antibodies against mAAT were raised in 
rabbits [2] and their ability to immunoprecipitate 
mAAT in liver homogenate was tested [2]. Rocket 
immunoelectrophoresis was carried out in 1% (w/v) 
agarose A [9] using 30.7 pg/cm’ gel of IgC anti- 
mAAT for 3-4 h at a field-strength of 10 V/cm in a 
LKB Multiphor chamber. Transferases A and B were 
isolated from 1 g rat liver by chromatography on 
phosphocellulose (column 80 X 6 mm), buffer 0.1 M 
sodium phosphate (pH 6.8)) containing 0.14 M NaCl, 
0.5 mM dithioerythritol and 20% (w/v) glycerine with 
a gradient from 0.28-0.63 M Na’(15 ml each) frac- 
tionated in 0.5 ml. Fused rocket immunoelectropho- 
resis was performed subsequently [lo]. Samples of 
5 1.11 from the chromatographic fractions were put into 
the wells and were allowed to diffuse radially for 4 h 
followed by electrophoresis during 10 h at 2 V/cm. 
3. Results and discussions 
The mAAT was proved to be immunologically dis- 
tinct from the mitochondrial acetyl-CoA acyltransfer- 
ase, from the cytosolic acetyl-CoA acetyltransferase 
[2] and from the peroxisomal acetyl-CoA acyltrans- 
ferase [3]. Therefore rocket immunoelectrophoresis 
can be employed to quantitate the amount of mAAT 
directly in liver homogenates with purified mAAT as 
a standard. Both forms A and B of this enzyme are 
measured simultanously in this way due to immuno- 
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F&t. Assay of mitochondriai acetylCoA acetyltransferase by rocket immunoeieclrophoresis of rat liver homogenates. The 
amounts of liver homogenate total protein @g) and of antigen protein (ng) added to each well are indicated. The wet& contain: 
(l-5) liver ttomogenate I; (G-10> fiver homogenate l1; (li-15) mAAT antigen. 
logical cross-reactivity [2]. Each run was calibrated 
by a standard of the purified antigen protein (f&l). 
The standard curve obtained (fig.2) was used to calcu- 
late the imm~~reacti~7e protein in the liver h’omoge- 
nates by linear regression. 
Ketone body concentrations in blood are elevated 
, 
i f 0 
I 
Fig.2. Standard curve for purified acetylCoA acetyltrans- 
ferase by rocket immunoelectrophoresis. 
in starved and diabetic animals reflecting increased 
rates of hepatic ketogenesis in these metabolic states 
(table 1). The mAAT content in livers from starved 
and alloxan diabetic rats did not si~i~cantIy differ 
from the content in livers from fed rats when based 
on 100 g body wt and/or on the DNA content. With 
liver wet wt as reference, however, the amount of 
immunoreactive protein was significantly elevated in 
starved rats. Thus the amount of mAAT protein 
appears not to correlate with the observed states of 
ketonaemia. 
The maximal acetoacetyl-CoA synthesizing capacity 
of mAAT of 18.8 .~mol . min-’ . 100 g body wt-’ was 
calculated from the ~m~i~noreact~ve protein content 
{table 1) and the specific activity of the purified 
mAAT (22.0 ,umol . mm-’ . mg protein-‘) [2]. This 
can account for the highest ketogenic rates observed 
in alloxan diabetic rats (IO.9 pmol . mm-’ . 100 g 
body wt-“) [12]. Obviously only a part of the maxi- 
mal synthesizing activity can be expressed in vivo due 
to the inhibitory action of CoASH and acetaacetyt- 
CoA on the mAAT [6,7,13]. CoASH may be of phys- 
iological importance to the ketogenic rates, for the 
ketone body production only correlates with the 
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Table 1 
Liver mitochondrial acetylCoA acetyltransferase content in rats of different metabolic states 
Metabolic Total ketone lmmunoreactive mAAT 
state of rats bodies in blood 
(fimol/ml) @g/g liver (Mg/loo g (pg/mg DNA) 
wet wt) body wt) 
Fed (12) 0.21 + 0.05 206.5 r 38.7 852.1 + 153.8 103.3 * 19.4 
Starved (12) l.Ol? 0.19a 281.8 + 45.Ya 783.7 + 131.9’ 96.1 * 15.7c 
Alloxan- 
diabetic (10) 9.67 f. 6.8b 196.1 2 40.5” 697.5 + 165.2’ _d _d 
a p < 0.001; b p < 0.01; ’ not significant; d not determined 
Ketone bodies were determined as in [ 111. Values are means *SD; no. expt. are in parenthesis 
acetyl-CoA/CoASH ratio [14,15]. 
The two forms of the mAAT, A and B, differ in 
isoelectric points and in specific activities [2]. Varia- 
tion of the relative amounts may thus be important 
for the actual rate of ketogenesis. These amounts of 
mAAT A and B were measured by a sequence of 
chromatography on phosphocellulose and fused rocket 
immunoelectrophoresis. A typical result of an immuno- 
chemical elution profile is shown in fig.3. From the 
area of the two peaks of immunoprecipitates a mean 
ratio A/B of 0.94 + 0.13 was calculated for the trans- 
ferases, which remained unchanged when blood ketone 
bodies increased. The relative amounts of A and B 
forms of mAAT can be concluded not to change 
B 
chromatography - 
Fig.3. Fused rocket immunoelectrophoresis. Immunochemical 
elution profile from chromatography on phosphocellulose. 
The relative amount of the two forms of mAAT A and B, 
were calculated from the areas of immunoprecipitates by 
graphical integration. Number of experiments: fed n = 13; 
starved n = 9; alloxan diabetic n = 5. 
during starvation or alloxan-induced diabetes. 
The amount of the immunoreactive mAAT does 
not correlate with the flux through ketogenic path- 
way in viva. However, these results do not exclude a 
possible regulatory role of mAAT in this pathway as 
a consequence of modulation of enzyme activity 
expressed under various metabolic conditions. 
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